SI
Shoulder Innovations, Inc.NYSEHealthcare$14.60-0.54%ClosedMarket Cap: $301.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.93
P/S
6.32
EV/EBITDA
-7.52
DCF Value
$-0.29
FCF Yield
-12.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.5%
Operating Margin
-55.6%
Net Margin
-85.3%
ROE
-89.5%
ROA
-23.8%
ROIC
-14.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $14.4M | 76.7% | $-8.5M | $-7.8M | $-0.38 | — |
| FY 2025 | $47.3M | 76.5% | $-26.3M | $-40.4M | $-0.00 | — |
| Q3 2025 | $11.8M | 76.2% | $-7.6M | $-8.7M | $-0.06 | — |
| Q2 2025 | $11.0M | 76.2% | $-5.9M | $-19.2M | $-0.95 | — |
| Q1 2025 | $10.1M | 76.9% | $-4.3M | $-4.7M | $-0.23 | — |
| Q4 2024 | $8.7M | 77.6% | $-3.5M | $-3.8M | $-0.19 | — |
| FY 2024 | $31.6M | 77.0% | $-14.7M | $-15.6M | $-0.77 | — |
| Q3 2024 | $7.5M | 76.5% | $-3.9M | $-4.1M | $-0.20 | — |
| Q2 2024 | $8.3M | 76.9% | $-4.0M | $-4.2M | $-0.21 | — |
| Q1 2024 | $7.2M | 76.8% | $-3.3M | $-3.6M | $-0.18 | — |
| Q4 2023 | $6.8M | 79.5% | $-2.4M | $-2.5M | $-0.13 | — |
| FY 2023 | $19.3M | 79.2% | $-10.9M | $-12.7M | $-0.63 | — |